JP Stock MarketDetailed Quotes

4569 Kyorin Pharmaceutical

Watchlist
  • 1518
  • +1+0.07%
20min DelayNot Open Nov 1 15:00 JST
98.07BMarket Cap16.37P/E (Static)

About Kyorin Pharmaceutical Company

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Company Profile

Symbol4569
Company NameKyorin Pharmaceutical
Founded1958-10-31
MarketTSE Prime
Employees2042
Fiscal Year Ends03-31
Address6, Kanda Surugadai 4-chome Chiyoda-ku
Zip Code100-0004
Phone03-6374-9700

Company Executives

  • Name
  • Position
  • Salary
  • Yutaka Ogihara
  • Director, President and Chief Executive Officer
  • --
  • Michiro Onota
  • Director and Chief Marketing Officer
  • --
  • Yasuji Kurose
  • Corporate Officer, Director, Chief Financial Officer, Director of Corporate Planning and CSto
  • --
  • Hiromi Watanabe
  • Independent Director
  • --
  • Noriyuki Shikanai
  • Independent Director
  • --
  • Ken Shigematsu
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data